Holy Cross 9th Annual Winter Oncology Symposium
Avatar

Re-Challenging with Immunotherapy in Metastatic NSCLC: Would Retreatment with anti-PD-L1 Develop a Recurrent Side Effect?

By Holy Cross 9th Annual Winter Oncology Symposium FEATURING Ibiayi Dagogo-Jack
By Holy Cross 9th Annual Winter Oncology Symposium FEATURING Ibiayi Dagogo-Jack
325 views
May 15, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Related Videos

17:20

2024 Intervention Selection & Sequencing in Early Stage NSCLC

Total Health

J. Porter

1.3K views
36:14

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

2024 ASCO® Annual Meeting Insights Hub

B. Halmos

817 views
18:47

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Total Health

W. Iams

6.4K views
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views
26:38

Metastatic EGFRm NSCLC: 1L Therapy Options

University of Colorado Cancer Center

T. Patil

363 views
06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse
11:54

ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients…

2024 ESMO Annual Meeting Insights Hub

R. Van den Begin

350 views
17:34

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

ecancer

L. Raez

909 views
19:33

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

ecancer

E. Felip, A. Spira, A. Passaro, A. Addeo

516 views
09:37

Controversies in NSCLC: Neoadjuvant vs. Adjuvant IO in Early Stage D…

Luis Raez

492 views
13:19

Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …

IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

E. Rodriguez

2.1K views
28:32

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

415 views
34:46

Photodynamic Therapy for Malignant Airway Disease

Fayez Kheir

475 views
14:17

WCLC 2024 Insights: Adjuvant vs. Neoadjuvant vs. Peri-Operative Ther…

Insights from 2024 WCLC

J. Von Der Thusen

189 views
10:17

New

Treatment Updates in Early Stage NSCLC - Advances in Thoracic Oncolo…

Total Health

J. Porter

163 views
09:40

PACIFIC Trial 5-Year OS Data: Clinical Implications in NSCLC

John Conibear

1.9K views
07:31

ASCO® 2023 Insights: "KEYNOTE-671 Trial Key Learnings & Clinical Imp…

Insights from 2023 ASCO® Annual Meeting

J. West

963 views
22:27

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

535 views
40:52

Respiratory Tract, EBUS, Molecular Biomarker Testing in Non-Small Ce…

Houston Methodist

S. Roy-Chowdhuri

294 views
14:22

Management of mNSCLC Without Actionable Mutations

Integrity CE

M. Baumgart, S. Liu

118 views
AUTOPLAY